- Current report filing (8-K)
13 Noviembre 2008 - 3:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 13, 2008
GENELABS TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
California
|
|
0-19222
|
|
94-3010150
|
|
|
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
|
|
505 Penobscot Drive, Redwood City, California
|
|
94063
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code (650) 369-9500
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of
the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition.
On November 13, 2008, Genelabs Technologies, Inc. announced its financial results for the
third quarter and first nine months of 2008. A copy of the related press release is furnished as
Exhibit 99.01 hereto.
The information in this Form 8-K (including Exhibit 99.01) shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
|
|
99.01
|
|
Press Release, dated November 13, 2008, entitled “Genelabs Reports Results for the Third
Quarter and First Nine Months of 2008.”
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
|
|
|
|
GENELABS TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
By: /s/ Frederick W. Driscoll
Name: Frederick W. Driscoll
|
|
|
|
|
|
Title: President and Chief Executive Officer
|
|
|
Date: November 13, 2008
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
99.01
|
|
Press Release of Genelabs Technologies, Inc., dated November 13, 2008
|
Genelabs (NASDAQ:GNLB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Genelabs (NASDAQ:GNLB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
